gemcitabine has been researched along with emodin in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 9 (81.82) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Easwaran, M; Manickam, M; Pillaiyar, T; Wendt, LL | 1 |
| Chen, Y; Guo, Q; Kang, M; Wu, Y; Xie, Q; Zhang, B | 1 |
| Chen, H; Guo, Y; Lin, S; Liu, A; Liu, J; Tan, W; Tong, H; Wang, Z; Wei, W | 1 |
| Chen, H; Guo, H; Guo, Y; Lin, S; Liu, D; Wei, W | 1 |
| Hu, YS; Ke, PY; Lin, SZ; Liu, A; Tang, LL; Wang, ZH | 1 |
| Liu, A; Tong, HF; Zeng, Y | 1 |
| Chen, H; Guo, HC; Lin, SZ; Liu, HB; Liu, JX; Ni, ZL; Tan, W; Tong, HF; Wang, ZH; Wei, WT | 1 |
| Bu, H; Chen, H; Guo, HC; Li, H; Lin, SZ; Liu, DL; Liu, HB; Ni, ZL; Tong, HF; Wang, ZH | 1 |
| Bu, HQ; Chen, H; Guo, HC; Li, HH; Li, W; Lin, SZ; Liu, DL; Luo, J; Tong, HF; Wang, ZH; Wei, WT; Wu, HY; Zuo, MM | 1 |
| Liu, A; Luo, J; Zhang, JH | 1 |
| Chen, H; Chen, KJ; Li, H; Li, Y; Lin, SZ; Liu, DL; Luo, J; Tong, HF; Zhang, JH; Zhang, W | 1 |
1 review(s) available for gemcitabine and emodin
| Article | Year |
|---|---|
The recent outbreaks of human coronaviruses: A medicinal chemistry perspective.
Topics: Antiviral Agents; Chemistry, Pharmaceutical; COVID-19; Disease Outbreaks; Drug Repositioning; Humans; Virus Internalization | 2021 |
10 other study(ies) available for gemcitabine and emodin
| Article | Year |
|---|---|
Potentiation of the effect of gemcitabine by emodin in pancreatic cancer is associated with survivin inhibition.
Topics: Animals; Antimetabolites, Antineoplastic; Caspase 3; Cell Division; Cell Line; Cell Line, Tumor; Cell Survival; Deoxycytidine; DNA Primers; Drug Synergism; Emodin; Gemcitabine; Gene Expression Regulation; Humans; Inhibitor of Apoptosis Proteins; Microtubule-Associated Proteins; Muscle, Skeletal; Pancreatic Neoplasms; Rats; Reverse Transcriptase Polymerase Chain Reaction; Suppression, Genetic; Survivin | 2009 |
Enhanced effect of gemcitabine by emodin against pancreatic cancer in vivo via cytochrome C-regulated apoptosis.
Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cytochromes c; Deoxycytidine; Drug Synergism; Emodin; Female; Gemcitabine; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Pancreatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Xenograft Model Antitumor Assays | 2011 |
[Emodin enhances antitumor effect of gemcitabine in model of SW1990 cell xenograft on athymic mouse].
Topics: Animals; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Cell Line, Tumor; Cell Transformation, Neoplastic; Cytochromes c; Deoxycytidine; Drug Synergism; Emodin; Female; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Nude; Proto-Oncogene Proteins c-bcl-2; Tumor Burden; Xenograft Model Antitumor Assays | 2010 |
[Role of nuclear factor-kappaB on emodin-induced sensitization of pancreatic cancer to gemcitabine].
Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Drug Resistance, Neoplasm; Emodin; Female; Gemcitabine; Humans; Inhibitor of Apoptosis Proteins; Ki-67 Antigen; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; NF-kappa B; Pancreatic Neoplasms; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Repressor Proteins; Survivin; Tumor Burden | 2011 |
[Effect of emodin combined gemcitabine on the growth and apoptosis of pancreatic cancer cell line BxPC-3 in vitro].
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Emodin; Gemcitabine; Humans; Pancreatic Neoplasms | 2011 |
Enhanced antitumor efficacy by the combination of emodin and gemcitabine against human pancreatic cancer cells via downregulation of the expression of XIAP in vitro and in vivo.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Down-Regulation; Drug Synergism; Emodin; Female; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Ki-67 Antigen; Mice; Mice, Inbred BALB C; Mice, Nude; NF-kappa B; Pancreatic Neoplasms; Tumor Burden; X-Linked Inhibitor of Apoptosis Protein; Xenograft Model Antitumor Assays | 2011 |
Emodin reverses gemcitabine resistance in pancreatic cancer cells via the mitochondrial apoptosis pathway in vitro.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Growth Processes; Cell Line, Tumor; Deoxycytidine; Drug Resistance, Neoplasm; Drug Synergism; Emodin; Gemcitabine; Humans; Mitochondria; Pancreatic Neoplasms; Protein Kinase Inhibitors | 2012 |
Emodin potentiates the antitumor effects of gemcitabine in PANC-1 pancreatic cancer xenograft model in vivo via inhibition of inhibitors of apoptosis.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; Caspases; Cell Line, Tumor; Deoxycytidine; Down-Regulation; Drug Synergism; Emodin; Gemcitabine; Humans; Inhibitor of Apoptosis Proteins; Ki-67 Antigen; Male; Mice; Mice, Inbred BALB C; Mice, Nude; NF-kappa B; Pancreatic Neoplasms; Survivin; Tumor Burden; X-Linked Inhibitor of Apoptosis Protein; Xenograft Model Antitumor Assays | 2012 |
[Emodin combined gemcitabine inhibited the growth of pancreatic cancer in vitro and in vivo and its mechanisms study].
Topics: Animals; bcl-2-Associated X Protein; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Emodin; Female; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Ki-67 Antigen; Mice; Mice, Inbred BALB C; Mice, Nude; Pancreatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Xenograft Model Antitumor Assays | 2012 |
Emodin sensitizes the gemcitabine-resistant cell line Bxpc-3/Gem to gemcitabine via downregulation of NF-κB and its regulated targets.
Topics: Antimetabolites, Antineoplastic; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Caspase 3; Caspase 9; Cell Line, Tumor; Cell Proliferation; Cell Shape; Deoxycytidine; Down-Regulation; Drug Resistance, Neoplasm; Drug Synergism; Emodin; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Inhibitor of Apoptosis Proteins; Inhibitory Concentration 50; NF-kappa B; Protein Binding; Survivin; X-Linked Inhibitor of Apoptosis Protein | 2013 |